Chlamydia trachomatis Incidence and Re-Infection among Young Women – Behavioural and Microbiological Characteristics
暂无分享,去创建一个
J. Kaldor | S. Garland | J. Hocking | L. Gurrin | J. Gunn | J. Twin | S. Tabrizi | C. Fairley | C. Bradshaw | M. Pirotta | V. Harindra | B. Donovan | Marcus Y. Chen | Jennifer Walker | N. Taylor | K. McNamee | E. Urban | S. Walker | M. Currie | H. Birden | F. Bowden | J. Walker
[1] P. Horner. Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy , 2012, Sexually Transmitted Infections.
[2] J. Kaldor,et al. Interventions to Increase Rescreening for Repeat Chlamydial Infection , 2012, Sexually transmitted diseases.
[3] H. Handsfield. Questioning azithromycin for chlamydial infection. , 2011, Sexually transmitted diseases.
[4] N. Verlander,et al. Genital chlamydial infection: association between clinical features, organism genotype and load. , 2011, Journal of medical microbiology.
[5] S. Garland,et al. Maximising retention in a longitudinal study of genital Chlamydia trachomatis among young women in Australia , 2011, BMC public health.
[6] S. Garland,et al. 'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women.' , 2011, BMC infectious diseases.
[7] Mirjam Kretzschmar,et al. The role of reinfection and partner notification in the efficacy of Chlamydia screening programs. , 2011, The Journal of infectious diseases.
[8] Robert E. Johnson,et al. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. , 2010, The Journal of infectious diseases.
[9] N. Low,et al. Risk of sequelae after Chlamydia trachomatis genital infection in women. , 2010, The Journal of infectious diseases.
[10] R. Verheij,et al. Trends in sexually transmitted infections in the Netherlands, combining surveillance data from general practices and sexually transmitted infection centers , 2010, BMC family practice.
[11] S. Garland,et al. Development and Evaluation of an ompA Quantitative Real-Time PCR Assay for Chlamydia trachomatis Serovar Determination , 2010, Journal of Clinical Microbiology.
[12] M. Unemo,et al. Characterisation of Chlamydia trachomatis by ompA sequencing and multilocus sequence typing in a Swedish county before and after identification of the new variant , 2009, Sexually Transmitted Infections.
[13] Richard T. Gray,et al. Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection. , 2009, The Journal of infectious diseases.
[14] L. Gurrin,et al. Screening pregnant women for chlamydia: what are the predictors of infection? , 2008, Sexually Transmitted Infections.
[15] J. Peipert,et al. Chlamydia Antibodies, Chlamydia Heat Shock Protein, and Adverse Sequelae After Pelvic Inflammatory Disease: The PID Evaluation and Clinical Health (PEACH) Study , 2008, Sexually transmitted diseases.
[16] S. M. Rogers,et al. Concordance of chlamydia trachomatis infections within sexual partnerships , 2007, Sexually Transmitted Infections.
[17] S. Lydersen,et al. Births and Ectopic Pregnancies in a Large Cohort of Women Tested for Chlamydia trachomatis , 2007, Sexually transmitted diseases.
[18] Helen H. Lee,et al. Chlamydia trachomatis Load at Matched Anatomic Sites: Implications for Screening Strategies , 2007, Journal of Clinical Microbiology.
[19] J. Hocking,et al. Antibiotic consumption and chlamydia prevalence in international studies. , 2006, Sexual health.
[20] S. Garland,et al. A chlamydia prevalence survey of young women living in Melbourne, Victoria. , 2006, Sexual health.
[21] A. Davies,et al. Incidence and reinfection rates of genital chlamydial infection among women aged 16–24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group , 2006, Sexually Transmitted Infections.
[22] P. Horner,et al. The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection , 2006, Sexually Transmitted Infections.
[23] C. Hoebe,et al. Reinfections, Persistent Infections, and New Infections After General Population Screening for Chlamydia trachomatis Infection in The Netherlands , 2005, Sexually transmitted diseases.
[24] R. Brunham,et al. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon- gamma. , 2005, The Journal of infectious diseases.
[25] R. Peeling,et al. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. , 2005, The Journal of infectious diseases.
[26] S. Franceschi,et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. , 2005, The Journal of infectious diseases.
[27] R. Kaslow,et al. Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents. , 2004, The Journal of infectious diseases.
[28] S. Garland,et al. Characterization of Chlamydia trachomatis omp1 Genotypes Detected in Eye Swab Samples from Remote Australian Communities , 2004, Journal of Clinical Microbiology.
[29] J. Fortenberry,et al. Patient-Delivered Partner Treatment With Azithromycin to Prevent Repeated Chlamydia trachomatis Infection Among Women: A Randomized, Controlled Trial , 2003, Sexually transmitted diseases.
[30] W. Whittington,et al. Quantitative culture of Chlamydia trachomatis: relationship of inclusion-forming units produced in culture to clinical manifestations and acute inflammation in urogenital disease. , 2001, The Journal of infectious diseases.
[31] J. Schillinger,et al. Repeat Chlamydia trachomatis infection in women: analysis through a surveillance case registry in Washington State, 1993-1998. , 2000, American journal of epidemiology.
[32] W. Stamm,et al. Quantitative Chlamydia trachomatis cultures: correlation of chlamydial inclusion-forming units with serovar, age, sex, and race. , 2000, The Journal of infectious diseases.
[33] H. Caldwell,et al. Subclinical Chlamydial Infection of the Female Mouse Genital Tract Generates a Potent Protective Immune Response: Implications for Development of Live Attenuated Chlamydial Vaccine Strains , 2000, Infection and Immunity.
[34] J B Carlin,et al. Analysis of binary outcomes in longitudinal studies using weighted estimating equations and discrete-time survival methods: prevalence and incidence of smoking in an adolescent cohort. , 1999, Statistics in medicine.
[35] G. Cloud,et al. Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study. , 1996, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[36] Gl Ridgway,et al. Principles and Practice of Infectious Diseases , 1990 .
[37] T. Schwarz,et al. [Genital chlamydial infections]. , 1986, Wiener klinische Wochenschrift.
[38] J. Paavonen,et al. Comparison of endometrial biopsy and peritoneal fluid cytologic testing with laparoscopy in the diagnosis of acute pelvic inflammatory disease. , 1985, American journal of obstetrics and gynecology.
[39] J. Fortenberry,et al. Repeated Chlamydia trachomatis genital infections in adolescent women. , 2010, The Journal of infectious diseases.
[40] D. Dean,et al. Correlating Chlamydia trachomatis infectious load with urogenital ecological success and disease pathogenesis. , 2006, Microbes and infection.
[41] W. M. Mac Kenzie,et al. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. , 1997, American journal of obstetrics and gynecology.
[42] G. Byrne,et al. Immunity to Chlamydia: comparison of human infections and murine models. , 1996, Research in immunology.
[43] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .